KKR struck a $3bn profit on its $5.5bn sale of Capsugel to Swiss pharma group Lonza, an exit which notched the firm an IRR of 36%.
Tag Archives | pharma
The firm saw the growing trend in pharma companies to outsource internal functions as an opportunity to invest in ProPharma.
Government intervention in drug pricing and more stringent regulation is pushing domestic pharmaceutical companies to acquire foreign assets.
The London-based firm is currently in market with its eighth flagship fund, targeting €1.6bn.
Bill Bithoney, chief physician executive for The BDO Center for Healthcare Excellence & Innovation, analyses the external influences on price and the role investors need to take in assessing cost effectiveness.
The 100 per cent sale to Ascendis Health includes divestments from minority co-investors such as Morgan Stanley Alternative Investment Partners.
The capital put into Madagascar’s leading pharmacy chain is a co-investment alongside Dutch development finance group FMO and an unnamed family office.
Richard Butt joins the innovative drugs discovery partnership after 20 years at pharma giant Pfizer.
The Clarus-led $50m funding round will be used to develop drugs to tackle the growing problem of multi-drug resistant infections in hospitals.
The raise to support the innovative drug trial was co-led by Frazier Healthcare Partners and Longitude Capital, with support from Aisling Capital.